Schaner Marci E, Ross Douglas T, Ciaravino Giuseppe, Sorlie Therese, Troyanskaya Olga, Diehn Maximilian, Wang Yan C, Duran George E, Sikic Thomas L, Caldeira Sandra, Skomedal Hanne, Tu I-Ping, Hernandez-Boussard Tina, Johnson Steven W, O'Dwyer Peter J, Fero Michael J, Kristensen Gunnar B, Borresen-Dale Anne-Lise, Hastie Trevor, Tibshirani Robert, van de Rijn Matt, Teng Nelson N, Longacre Teri A, Botstein David, Brown Patrick O, Sikic Branimir I
Stanford University School of Medicine, Stanford, California 94305-5151, USA.
Mol Biol Cell. 2003 Nov;14(11):4376-86. doi: 10.1091/mbc.e03-05-0279. Epub 2003 Sep 5.
We used DNA microarrays to characterize the global gene expression patterns in surface epithelial cancers of the ovary. We identified groups of genes that distinguished the clear cell subtype from other ovarian carcinomas, grade I and II from grade III serous papillary carcinomas, and ovarian from breast carcinomas. Six clear cell carcinomas were distinguished from 36 other ovarian carcinomas (predominantly serous papillary) based on their gene expression patterns. The differences may yield insights into the worse prognosis and therapeutic resistance associated with clear cell carcinomas. A comparison of the gene expression patterns in the ovarian cancers to published data of gene expression in breast cancers revealed a large number of differentially expressed genes. We identified a group of 62 genes that correctly classified all 125 breast and ovarian cancer specimens. Among the best discriminators more highly expressed in the ovarian carcinomas were PAX8 (paired box gene 8), mesothelin, and ephrin-B1 (EFNB1). Although estrogen receptor was expressed in both the ovarian and breast cancers, genes that are coregulated with the estrogen receptor in breast cancers, including GATA-3, LIV-1, and X-box binding protein 1, did not show a similar pattern of coexpression in the ovarian cancers.
我们使用DNA微阵列来表征卵巢表面上皮癌中的整体基因表达模式。我们鉴定出了一些基因群组,它们能够区分透明细胞亚型与其他卵巢癌、I级和II级浆液性乳头状癌与III级浆液性乳头状癌,以及卵巢癌与乳腺癌。基于基因表达模式,6例透明细胞癌与36例其他卵巢癌(主要是浆液性乳头状癌)得以区分。这些差异可能有助于深入了解与透明细胞癌相关的较差预后和治疗抗性。将卵巢癌中的基因表达模式与已发表的乳腺癌基因表达数据进行比较,发现了大量差异表达基因。我们鉴定出一组62个基因,它们能够正确分类所有125例乳腺癌和卵巢癌标本。在卵巢癌中表达更高的最佳鉴别基因包括PAX8(配对盒基因8)、间皮素和 Ephrin-B1(EFNB1)。尽管雌激素受体在卵巢癌和乳腺癌中均有表达,但在乳腺癌中与雌激素受体共调节的基因,包括GATA-3、LIV-1和X盒结合蛋白1,在卵巢癌中并未表现出类似的共表达模式。